Abstract
This is an update to a paper that appeared in the very first issue of the Journal of Generic Medicines in October 2003. Over the past few years, pharmaceutical manufacturers have started to diversify their portfolios to include generic medicines as a way to maximise their investment in patented drugs. With this dynamic as context, understanding the development and construction of a generic name may be helpful both to the manufacturer of patented drugs who wants to support the perception of distinctiveness among competition, as well as to the generics marketer who wants to leverage the legacy of previously patented drugs. This paper intends to define generic names, explain their purpose and the challenges they pose to manufacturers, provide some guidance on their development, and identify how the non-proprietary name can support marketing opportunities.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
